Treatment of Negative Symptoms of Schizophrenia by rTMS
RecruitingNCT06595654Phase: NAStarted 2023-06-09
Summary
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under thes
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Etablissement Public de Santé de Ville-EvrardNeuilly-sur-Marne, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06595654